 Kathleen Dorris
Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 9 | 2022 | 979 | 1.660 |
Why?
| | Glioma | 4 | 2021 | 294 | 1.280 |
Why?
| | Antineoplastic Agents | 3 | 2018 | 1879 | 0.600 |
Why?
| | Spinal Neoplasms | 1 | 2017 | 28 | 0.560 |
Why?
| | Ependymoma | 4 | 2019 | 155 | 0.550 |
Why?
| | Ganglioglioma | 1 | 2017 | 31 | 0.550 |
Why?
| | Electric Stimulation Therapy | 1 | 2017 | 56 | 0.540 |
Why?
| | Clinical Trials, Phase I as Topic | 1 | 2016 | 45 | 0.540 |
Why?
| | Molecular Targeted Therapy | 1 | 2016 | 347 | 0.450 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 1355 | 0.400 |
Why?
| | Histones | 1 | 2017 | 535 | 0.400 |
Why?
| | Chromosomes, Human, Pair 1 | 2 | 2019 | 66 | 0.310 |
Why?
| | Infratentorial Neoplasms | 2 | 2019 | 45 | 0.300 |
Why?
| | Child | 11 | 2022 | 18412 | 0.210 |
Why?
| | Neoplasms | 1 | 2016 | 2097 | 0.210 |
Why?
| | Neoplasm Grading | 2 | 2021 | 242 | 0.210 |
Why?
| | Prognosis | 4 | 2019 | 3329 | 0.210 |
Why?
| | Germinoma | 1 | 2022 | 12 | 0.200 |
Why?
| | Pineal Gland | 1 | 2022 | 13 | 0.200 |
Why?
| | Pinealoma | 1 | 2022 | 11 | 0.200 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.200 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 17 | 0.200 |
Why?
| | Drug Screening Assays, Antitumor | 2 | 2021 | 180 | 0.190 |
Why?
| | Radiation | 1 | 2021 | 24 | 0.190 |
Why?
| | Hydrocephalus | 1 | 2022 | 83 | 0.190 |
Why?
| | Vinblastine | 1 | 2020 | 63 | 0.180 |
Why?
| | Carboplatin | 1 | 2020 | 135 | 0.170 |
Why?
| | Neoplasms, Neuroepithelial | 1 | 2019 | 17 | 0.170 |
Why?
| | Survival Rate | 2 | 2020 | 1644 | 0.160 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 12 | 0.160 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.160 |
Why?
| | Chemoradiotherapy | 1 | 2019 | 188 | 0.150 |
Why?
| | Craniopharyngioma | 1 | 2019 | 65 | 0.150 |
Why?
| | Combined Modality Therapy | 2 | 2019 | 1121 | 0.150 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 179 | 0.150 |
Why?
| | Pituitary Neoplasms | 1 | 2019 | 157 | 0.150 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2021 | 1141 | 0.140 |
Why?
| | Chromosome Aberrations | 1 | 2017 | 135 | 0.140 |
Why?
| | Neuroimaging | 1 | 2019 | 249 | 0.140 |
Why?
| | Radiotherapy | 1 | 2017 | 176 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2018 | 1518 | 0.120 |
Why?
| | Follow-Up Studies | 2 | 2020 | 4411 | 0.120 |
Why?
| | Safety | 1 | 2016 | 297 | 0.120 |
Why?
| | Adolescent | 4 | 2022 | 17841 | 0.120 |
Why?
| | Cell Line, Tumor | 2 | 2018 | 2710 | 0.110 |
Why?
| | Biomarkers, Tumor | 1 | 2019 | 1040 | 0.110 |
Why?
| | Humans | 12 | 2022 | 114662 | 0.100 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3532 | 0.090 |
Why?
| | Infant | 2 | 2020 | 7961 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2022 | 12546 | 0.080 |
Why?
| | Child, Preschool | 2 | 2020 | 9114 | 0.080 |
Why?
| | Male | 6 | 2022 | 55583 | 0.080 |
Why?
| | Infant, Newborn | 1 | 2020 | 5045 | 0.080 |
Why?
| | Female | 5 | 2022 | 59493 | 0.070 |
Why?
| | Mutation | 1 | 2017 | 3345 | 0.070 |
Why?
| | Young Adult | 2 | 2021 | 10466 | 0.070 |
Why?
| | Computer Simulation | 2 | 2021 | 872 | 0.060 |
Why?
| | Treatment Outcome | 1 | 2017 | 9088 | 0.050 |
Why?
| | Gene Ontology | 1 | 2021 | 46 | 0.050 |
Why?
| | DNA Copy Number Variations | 1 | 2021 | 154 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 314 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 453 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2019 | 849 | 0.040 |
Why?
| | Overweight | 1 | 2022 | 471 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 555 | 0.040 |
Why?
| | Drug Approval | 1 | 2018 | 78 | 0.040 |
Why?
| | Receptors, HIV | 1 | 2017 | 23 | 0.040 |
Why?
| | Mucin-1 | 1 | 2017 | 18 | 0.040 |
Why?
| | Cytogenetic Analysis | 1 | 2017 | 29 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2019 | 698 | 0.040 |
Why?
| | DNA Methylation | 1 | 2021 | 495 | 0.040 |
Why?
| | Microarray Analysis | 1 | 2017 | 118 | 0.040 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2017 | 79 | 0.030 |
Why?
| | Risk Factors | 2 | 2022 | 8632 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2017 | 103 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 304 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 725 | 0.030 |
Why?
| | Algorithms | 1 | 2022 | 1468 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 1958 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2017 | 511 | 0.030 |
Why?
| | Nuclear Proteins | 1 | 2017 | 591 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2019 | 2186 | 0.030 |
Why?
| | Cohort Studies | 1 | 2021 | 4895 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2362 | 0.020 |
Why?
| | DNA-Binding Proteins | 1 | 2017 | 1314 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2285 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2508 | 0.020 |
Why?
| | Transcription Factors | 1 | 2017 | 1528 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 3046 | 0.020 |
Why?
| | Mice | 1 | 2019 | 14863 | 0.010 |
Why?
| | Animals | 1 | 2019 | 31699 | 0.010 |
Why?
|
|
Dorris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|